WHO warns of fake Ozempic medicines used for diabetes and weight loss
13 oC
13 oC
Güneşli
13 oC
Güneşli
The World Health Organization (WHO) issued a warning about counterfeit versions of semaglutide medications, including the brand name Ozempic.
These drugs are prescribed to manage type 2 diabetes and have become increasingly popular for weight loss, leading to a rise in counterfeiting.
The WHO identified three instances of falsified semaglutide products in October 2023 (Brazil and UK) and December 2023 (US). They urged healthcare professionals and the public to be cautious of these imitations.
Counterfeit semaglutide might lack essential ingredients, causing uncontrolled blood sugar levels or weight gain. In some cases, they may contain unlisted active ingredients like insulin, leading to unpredictable health risks.
While effective, semaglutide's high price makes it unsuitable for large-scale use in resource-limited settings. The WHO recommends more affordable medications with similar effects for diabetes management.
The WHO is developing rapid advice guidelines on using GLP-1 receptor agonists, including semaglutides, for treating obesity in adults as part of a comprehensive care model. GLP-1 RAs are a class of medicines that lower blood sugar and support weight loss.
The WHO urges all healthcare professionals, regulatory authorities, and the public to remain vigilant and report any suspicious medicines to the relevant authorities immediately. (ILKHA)
LEGAL WARNING: All rights of the published news, photos and videos are reserved by İlke Haber Ajansı Basın Yayın San. Trade A.Ş. Under no circumstances can all or part of the news, photos and videos be used without a written contract or subscription.
The World Health Organization (WHO) issued a dire warning on Wednesday, stating that Gaza’s health system is on the verge of a “complete shutdown” due to a critical lack of fuel.
A 55-year-old man from Gölbaşı village in Sivas’ Zara district has become the sixth victim of Crimean-Congo Haemorrhagic Fever (CCHF) in the region this year, health authorities confirmed on Saturday.
Australia has recorded its first case of the mpox clade 1b variant, known to cause more severe illness, according to the Australian Centre for Disease Control (CDC).
Türkiye’s household landscape is undergoing significant changes, with the average household size shrinking, one-person households on the rise, and stark regional differences in family structures.
